Abstract The visual responses of vertebrates are sensitive to the overall composition of retinal interneurons including amacrine cells, which tune the activity of the retinal circuitry. The expression of Paired-homeobox 6 (PAX6) is regulated by multiple cis-DNA elements including the intronic aenhancer, which is active in GABAergic amacrine cell subsets. Here, we report that the transforming growth factor ß1-induced transcript 1 protein (Tgfb1i1) interacts with the LIM domain transcription factors Lhx3 and Isl1 to inhibit the a-enhancer in the post-natal mouse retina.
Introduction
The retina is a primary sensory tissue that receives light stimulus and converts it into electrical signals, which are then sent to the brain for further processing. After light detection by rod and cone photoreceptors, the first step in visual processing occurs in bipolar cells that are either stimulated or inhibited by light-absorbed photoreceptors (Masland, 2012) . The activities of bipolar cells are then tuned by horizontal cells while they receive visual input from the photoreceptors and by amacrine cells while they deliver the signals to retinal ganglion cells (RGCs) (Hoon et al., 2014; Masland, 2012) . The amacrine cells do not simply convey the signals from bipolar cells, but they also invert the signals by releasing inhibitory neurotransmitters such as g-aminobutyric acid (GABA) and glycine. Therefore, even subtle changes in the composition and connectivity of amacrine cell subsets might alter the output of the retina, modifying the visual information sent to the brain.
The neurons of the vertebrate retina develop in an ordered fashion from multipotent retinal progenitor cells (RPCs) (Cepko, 2014) . A number of transcription factors with precise temporal and spatial expression patterns control the composition of retinal neurons via the hierarchical and reciprocal regulation of other transcription factor expression (Zagozewski et al., 2014) . Thus, the alterations of transcription factors that specify retinal neuron subtypes should modify visual output of mature retina. Those transcription factors include Pax6 in amacrine cells (Marquardt et al., 2001 ), Vsx2 in bipolar cells (Liu et al., 1994) , Otx2 in bipolar cells and photoreceptors (Koike et al., 2007; Nishida et al., 2003) , and Lhx2 and Sox2 in Mü ller glia and certain amacrine subtypes (de Melo et al., 2012; Gordon et al., 2013; Lin et al., 2009) . These transcription factors are not only expressed in the earlier optic structures to play critical roles in the eye and brain development (Danno et al., 2008; Glaser et al., 1994; Yun et al., 2009) , but also in the mature retinal neurons to support the survival and functions of the neurons (de Melo et al., 2012; Kim et al., 2015) . However, the mechanisms underlying the recurrent expression of transcription factors in the retinal lineage are still largely unknown.
Pax6 is one of the earliest transcription factors expressed in the eye field, and as such, it is considered as a master regulator of eye development Hanson and Van Heyningen, 1995) . Pax6 contains two DNA-binding domains-a paired domain (PD) and a homeodomain (HD)-linked via a glycine-rich domain, and activates target gene transcription through its C-terminal proline-, serine-, and threonine-rich (PST) domain (Epstein et al., 1994; Xu et al., 1999a) . Multiple cis-regulatory elements govern Pax6 expression in various mouse tissues (Kammandel et al., 1999; Xu et al., 1999b) . The 'a-enhancer', located within intron 4 of the Pax6 gene, is active in the retina from embryo to adult (Kammandel et al., 1999; Marquardt et al., 2001; Plaza et al., 1995) . This retina-specific enhancer activity sustains in RPCs in the peripheral retina of the embryos and regulates neuronal differentiation in a context-dependent manner (Marquardt et al., 2001 ). In the mature eye, the a-enhancer is active in cells of the ciliary body and amacrine cells of the retina (Marquardt et al., 2001) .
The a-enhancer contains multiple binding sites for transcription factors, including the auto-stimulatory Pax6 (Kammandel et al., 1999) , the stimulatory Msx1 (Kammandel et al., 1999) and Pou4f2 eLife digest The retina is a light-sensitive layer of tissue that lines the inside of the eye. This tissue is highly organized and comprises a variety of different nerve cells, including amacrine cells. Together, these cells process incoming light and then trigger electrical signals that travel to the brain, where they are translated into an image. Changes in the nerve cell composition of the retina, or in how the cells connect to each other, can alter the visual information that travels to the brain.
The nerve cells of the retina are formed before a young animal opens its eyes for the first time. Proteins called transcription factors -which regulate the expression of genes -tightly control how the retina develops. For example, a transcription factor called Pax6 drives the development of amacrine cells. Several other transcription factors control the production of Pax6 by binding to a section of DNA known as the "a-enhancer". However, it is not clear how regulating Pax6 production influences the development of specific sets of amacrine cells. Kim et al. reveal that a protein known as Tgfb1i1 interacts with two transcription factors to form a "complex" that binds to the a-enhancer and blocks the production of a particular form of Pax6. In experiments performed in mice, the loss of Tgfb1i1 led to increased production of this form of Pax6, which resulted in the retina containing more of a certain type of amacrine cell that produce a molecule called GABA. Mice lacking Tgfb1i1 show a stronger response to light and are therefore comparable to people who are too sensitive to light. On the other hand, mice with a missing a section of the a-enhancer DNA have fewer amacrine cells releasing GABA and become less sensitive to light and are comparable to people who have difficulty detecting weaker light signals.
The findings of Kim et al. suggest that an individual's sensitivity to light is related, at least in part, to the mixture of amacrine cells found in their retina, which is determined by certain transcription factors that target the a-enhancer. (Plaza et al., 1999) , and the inhibitory Pax2 (Kammandel et al., 1999; Schwarz et al., 2000) and Vax1 (Mui et al., 2005) . Although the inhibition of a-enhancer activity by Vax1 has been shown to be crucial for the development of the retina-optic stalk border (Mui et al., 2005) , the roles the other transcription factors that bind the a-enhancer in the retina remain unclear. In this study, we show that regulation of Pax6 expression through the a-enhancer fine tunes amacrine cell subtype composition, and consequently, the visual output of the retina.
Results
Identification of Lhx3 and Tgfb1i1 as Pax6 a-enhancer binding proteins in mouse retina According to DNase footprinting (DF) results, the Pax6 a-enhancer contains four retina-specific transcription factor-binding sites called DF1-4 (Plaza et al., 1995) . It also contains an auto-regulatory Pax6 binding sequence (PBS; Figure 1A ). The AT-rich region designated DF4 recruits both positive and negative regulators expressed in the optic vesicle and embryonic retina (Lakowski et al., 2007; Mui et al., 2005; Plaza et al., 1999; Schwarz et al., 2000) . Still, the transcription factors responsible for regulating a-enhancer activity in the post-natal retina are not yet known.
In a proteomic screen for DF4-binding proteins in R28 rat RPCs, we identified Lhx3 (LIM domain homeobox 3) and Hic-5 (hydrogen peroxide induced clone 5)/Tgfb1i1 (tumor growth factor-b1 induced transcript one protein)/Ara55 (androgen receptor-associated protein 55) as potential candidates ( Figure 1B ; see Materials and methods for details). These proteins share the LIM (LIN-11, Isl1, or MEC-3) protein-protein interaction domain (Karlsson et al., 1990; Way and Chalfie, 1988) . In addition, Lhx3 contains a homeodomain and acts as a transcription factor (Bridwell et al., 2001; Roberson et al., 1994) . Tgfb1i1 has four leucine-rich domains (LDs), which mediate interactions with other LD-containing protein, and four LIM domains, which mediate both self-oligomerization and interactions with other LIM domain-containing proteins (Mori et al., 2006; Nishiya et al., 1999) .
Lhx3 is absent from the embryonic mouse retina, but is expressed in bipolar cells beginning around the first post-natal week (Figure 1C , top; Figure 1 -figure supplement 1A) (Balasubramanian et al., 2014) . Tgfb1i1 is expressed in most of post-natal retina, but is absent from the embryonic and adult mouse retinas (Figure 1C , bottom; Figure 1 -figure supplement 1B). We also noticed Lhx3-and Tgfb1i1-expressing cells in P8 retinas show no Pax6 a-enhancer activity ( Figure 1C) , as visualized by an GFP reporter in Pax6 a-enhancer::Cre-IRES-GFP (P6a-CreiGFP) mice (Marquardt et al., 2001 ). This suggests a potential negative relationship between these LIM domain proteins and the a-enhancer activity.
To validate our screening results, we further examined the binding of those LIM-domain containing proteins in P7 retinal nuclear extracts to DF4 sequence, and found Lhx3 and Tgfb1i1 in these extracts bind wild-type DF4 dsDNA (DF4-WT) but not mutant DF4 dsDNA (DF4-MUT) in which the 5'-ATTA-3' homeodomain target sequence is replaced with 5'-CGGC-3' (Figure 1-figure supplement 2A). Not only the endogenous Lhx3 but also in vitro-translated Lhx3 specifically binds the DF4 oligomer ( Figure 1-figure supplement 2B ). In vitro-translated Tgfb1i1, however, lacks a DNA-binding motif, and so does not bind the DF4 oligomer (Figure 1-figure supplement 2B ). This suggests Tgfb1i1 binds the a-enhancer indirectly, possibly via an interaction with another DF4-binding protein like Lhx3.
To determine whether Lhx3 and Tgfb1i1 bind the a-enhancer in vivo, we performed a chromatin immunoprecipitation (ChIP) analysis using rabbit polyclonal antibodies raised against Lhx3 or Tgfb1i1. We checked the ChIP DNA fragments isolated from P7 retinas for two mouse Pax6 gene sequences located in the ectodermal enhancer of the 5'-UTR and the a-enhancer of intron 4 using PCR ( Figure 1D ) and quantitative PCR (qPCR; Figure 1E ). Since both of these enhancer elements include auto-regulatory Pax6 binding sequences (Aota et al., 2003; Kammandel et al., 1999) , we used ChIP DNA fragments obtained with anti-Pax6 rabbit IgG (a-Pax6) as a positive control and those obtained with pre-immune rabbit IgG (RbIgG) as a negative control. We found that, in the mouse retina, Lhx3 and Tgfb1i1 interact specifically with the a-enhancer but not the ectodermal enhancer ( Figure 1D,E) .
As other LIM domain-containing transcription factors can target the same DNA sequences as Lhx3 (Gehring et al., 1994) , we also determined whether other LIM domain transcription factors expressed in the post-natal retina, such as Islet-1 (Isl1) and Lhx2 (Balasubramanian et al., 2014) (Figure 1-figure supplement 3A) , also can bind the Pax6 a-enhancer DF4 sequence. We found Lhx2, but not Isl1, shows specific binding to the DF4 sequence (Figure 1-figure supplement 3C ). Isl1 instead binds DF3, which contains the predicted Isl1 binding sequence 5'-CATTAG-3' (Lee et al., 2008; Leonard et al., 1992) (Figure 1-figure supplement 3D) . Conversely, the DF4-recognizing Nuclear extracts from R28 rat retinal precursor cells were incubated with DF4 dsDNA oligomers with single-stranded 5'-(GT) 5 -3' overhangs. DF4 oligomer-protein complexes were then added to Sepharose 6B columns conjugated with single-stranded DNA (ssDNA) of 5'-(CA) 5 -3', which is complementary to the single-stranded overhang sequence of the oligomer, or 5'-(TG) 5 -3' non-specific binding control. Proteins bound to the ssDNA column were eluted for SDS-PAGE and detected by silver staining. Protein bands specifically enriched in the (CA) 5 column were then eluted from the gel and digested for mass spectrometric identification. This analysis identified the two bands marked by arrows as Lhx3 and Tgfb1i1. (C) Lhx3 and Tgfb1i1 expression in post-natal day 8 (P8) Pax6 a-enhancer::Cre-IRES-GFP (P6a-CreiGFP) mouse retinas stained with rabbit anti-Lhx3 (top) and anti-Tgfb1i1 (bottom) antibodies (red). These were also co-stained with a chick anti-GFP antibody (green). Scale bars, 100 mm. (D) DNA fragments bound to Pax6, Lhx3, and Tgfb1i1 in P7 mouse retinas were isolated by chromatin immunoprecipitation (ChIP) using rabbit polyclonal antibodies against each protein. Lhx3 and Isl1 inhibit Pax6 a-enhancer activity in a Tgfb1i1-dependent manner
Lhx3 is expressed in cone bipolar cells but not in amacrine cells, including the Pax6 a-GFP-positive subpopulation ( Figure 1C ; Figure 1 -figure supplement 3A,B) (Balasubramanian et al., 2014) . On the contrary, Lhx2 is expressed primarily in Mü ller glia (Balasubramanian et al., 2014) but also in amacrine cells, including those with a-enhancer activity (Figure 1-figure supplement 3A,B) . Lhx9 is also expressed in amacrine cells (Balasubramanian et al., 2014) , about 60% of which show Pax6 aenhancer activity (Figure 1-figure supplement 3A,B) . Both Lhx2 and Lhx9 activate the Pax6 a-luciferase reporter in a dose-dependent manner (Figure 2A,B) . In contrast, Lhx3 and Lhx4 do not affect a-enhancer activity alone (Figure 2A ), but they antagonize Pax6-induced activation of the aenhancer ( Figure 2B ). Isl1 is expressed in ON bipolar cells and cholinergic amacrine cells (Elshatory et al., 2007; Galli-Resta et al., 1997; Haverkamp et al., 2003) , but not in Pax6 aenhancer-active amacrine cells (Figure 1-figure supplement 3A ,B). Isl1 does not affect Pax6 a- enhancer activity alone, but it does activate the enhancer in the presence of Pax6 (Figure 2A,B) . Together, these results suggest LIM domain transcription factors in the mouse retina can be categorized based on how they affect Pax6 a-enhancer-some are stimulatory (i.e., Lhx2 and Lhx9), some are inhibitory (i.e., Lhx3 and Lhx4), and some are context-sensitive (i.e., Isl1). Tgfb1i1, although it is unable to bind the a-enhancer directly (Figure 1-figure supplement 2B ), inhibits Pax6-induced a-enhancer activity upon overexpression ( Figure 2C ). This inhibition of the aenhancer is even more significant when Tgfb1i1 is co-expressed with both Lhx3 and Isl1 ( Figure 2D , E). We hypothesized that multiple LIM domains of Tgfb1i1 allow it to form a multi-protein complex that blocks a-enhancer-dependent gene expression. To assess this, we co-expressed these LIM domain transcription factors with Lmo4 (LIM-domain-only 4), which prevents Isl1 and Lhx3 from interacting with one another or with other LIM domain-containing proteins (Thaler et al., 2002) . Lmo4 alone caused a dose-dependent increase in a-enhancer activity and potentiated Pax6-induced activation of the a-enhancer ( Figure 2C ). In the presence of Lmo4, Lhx3 and Isl1 cannot inhibit the aenhancer ( Figure 2D ). Thus, Tgfb1i1 and Lmo4 appear to oppositely regulate a-enhancer activity by antagonistically modulating the formation of the LIM domain transcription factor complex.
Pax6 and Tgfb1i1 competitively bind Isl1 to antagonistically regulate the a-enhancer
We next used co-immunoprecipitation to determine whether Isl1, Lhx3, and Tgfb1i1 form a LIM protein complex in P7 mouse retina. We were able to detect Isl1 in complexes recovered using Lhx3 and Tgfb1i1, which are also capable of precipitating one another ( Figure 3A ). This suggests these three proteins may exist as a complex in the retina. To further examine the molecular nature of this LIM protein complex, we used combinatorial transfections of constructs encoding Lhx3, Isl1, and Tgfb1i1 into human embryonic kidney 293T (HEK293T) cells. The results of these transfections are summarized in Figure 3 -source data 1.
In the co-immunoprecipitation experiments, we found that Isl1 binds to Lhx3 with its homeodomain (HD) and/or LIM binding domain (LBD), as reported previously (Thaler et al., 2002) , whereas it interacts with Tgfb1i1 with its LIM domain(s) ( Figure 3B ). We further tested whether Tgfb1i1 binds Lhx3 and Isl1 separately or whether they form a complex of Lhx3-Tgfb1i1-Isl1. We found overexpressed Tgfb1i1 further enhanced the association between Lhx3 and Isl1 ( Figure 3C ). Lmo4, in contrast, induces a dose-dependent decrease in the association between Isl1 and Lhx3 ( Figure 3D ). Collectively, these results suggest Tgfb1i1 links Isl1 and Lhx3 to form a hetero-tetrameric (or larger) complex while Lmo4 interferes with the complex formation.
It is possible Pax6 interacts with the homeodomains of Isl1 and Lhx3 to form a Pax6-LIM protein complex, since Pax6 reportedly interacts with various homeodomain-containing proteins (Granger et al., 2006; Mikkola et al., 2001) . We also found Pax6 interacts only with Isl1, but not Lhx3, via its paired domain (PD) ( Figure 3E The DF3 and DF4, which are separated by an auto-regulatory PBS, are respective targets of Isl1 and Lhx3 ( Figure 1A ; Figure 1 -figure supplement 3C,D). Thus, Pax6 binding to the PBS may hinder the binding of Isl1-Tgfb1i1-Lhx3 complex to the DF3 and DF4 sequences, and vice versa. Using ChIP analyses in the cultured cells, we found Isl1, Lhx3, and Tgfb1i1 reduce the binding of Pax6 to the a-enhancer when all three are co-expressed but not when expressed individually ( Figure 3G , three right graphs). Conversely, Pax6 expression interferes with the access of Tgfb1i1 to the aenhancer ( Figure 3G , rightmost graph). Pax6 does not affect Lhx3 binding to the a-enhancer, but it promotes Isl1 binding ( Figure 3H , two center graphs). Together, these molecular interaction results suggest two different transcription factor complexes occupying the a-enhancer region. The Isl1-Pax6 complex binds to the DF3 and PBS and activates the a-enhancer ( Figure 3H , top), whereas the Isl1-Tgfb1i1-Lhx3 complex binds to DF3 and DF4 to cover the area between those two sequences and inhibit the access of Pax6 to DF3 ( Figure 3H , bottom).
Tgfb1i1
À/À retinas have excessive Pax6 a-enhancer-active GABAergic amacrine cells
We, next, examined the Pax6 a-enhancer activity by detecting Pax6 a-GFP-positive cells in P14 Tgfb1i1 À/À mice in comparison to Tgfb1i1 +/+ (wild-type, WT) littermates to validate the molecular mechanism proposed by our in vitro data in vivo. In support of the idea that Tgfb1i1 plays an important role in the inhibition of Pax6 a-enhancer, the Tgfb1i1 À/À mouse retinas show more cells positive for the Pax6 a-GFP reporter than the retinas of their Tgfb1i1 +/+ littermates ( Figure 4A ,B). We also We classified amacrine cells positive for Gad67 (glutamate decarboxylase 67 kDa), GABA, and Bhlhb5 (basic helix-loop-helix domain containing, class B, 5) as GABAergic; cells positive for ChAT (choline acetyl transferase) as cholinergic; and cells positive for GlyT1 (glycine transporter 1) as glycinergic. Among those amacrine cell subtypes, only GABAergic amacrine cells showed a significant increase, while the numbers of cholinergic and glycinergic amacrine cells remain unchanged ( Figure 4C,D) . Moreover, the Pax6 a-GFP-positive cells are mainly GABAergic amacrine cells ( bipolar cells ( Figure 4E,F) . However, the numbers of type-2 OFF bipolar cells, which are positive to Bhlhb5 and Recoverin, are not greatly different between Tgfb1i1 +/+ and Tgfb1i1 À/À mouse retinas (Figure 4C-F; Figure 4-figure supplement 1) . The results therefore suggest that Tgfb1i1 is necessary for the development of Vsx1-positive OFF bipolar cells, except for type-2 subset, in mouse retina.
We also tried to investigate the roles of Lhx3 in the post-natal mouse retina, which cannot develop in Lhx3-deficient mice that die perinatally (Sheng et al., 1996) . We, thus, electroporated DNA constructs encoding Cas9 endonuclease and single guide RNA (sgRNA) targets to mouse Lhx3 sequence, together with the pCAGIG DNA construct expressing EGFP (enhanced green fluorescent protein), into P0 mouse retinas (Figure 4-figure supplement 2A ; see Materials and methods for details). We then examined the fates of EGFP-positive cells, which supposedly co-express Cas9 and the Lhx3 sgRNA, in the mouse retinas at P14. We found GABAergic amacrine cell identities of the retinal cells expressing the constructs were significantly enhanced, whereas OFF bipolar cell identities of the cells were remarkably diminished (Figure 4-figure supplement 2B-D) . Collectively, our results suggest that Tgfb1i1 supports the development of OFF bipolar cell subsets, while it antagonizes the development of GABAergic amacrine cell subset, by forming Lhx3-containing protein complex that inhibits Pax6 a-enhancer activity in post-natal mouse retina.
Positive correlation between Pax6 a-enhancer-driven Pax6DPD expression and GABAergic amacrine cell fate
In P14 mouse retinas, Lhx3-positive bipolar cells co-expressing Isl1 comprise only 20% of total Lhx3-positive cells ( Figure 5 -figure supplement 1B,C). In contrast, 82% of Lhx3-positive retinal cells coexpress Isl1 at P7, which is when Tgfb1i1 is expressed in most retinal cell types apart from amacrine cells ( Figure 5-figure supplement 1A,C) . This suggests the Isl1-Tgfb1i1-Lhx3 complex may form in the retinal cells around the first post-natal week at the peak of bipolar cell development (Morrow et al., 2008; Rapaport et al., 2004) . Supporting this, the interaction between Isl1 and Lhx3 is significantly reduced in P7 Tgfb1i1 À/À retinas ( Figure 5A , top). This might trigger an overactivation of Pax6 transcription, driven by the a-enhancer.
However, Pax6 levels did not differ in Tgfb1i1 À/À and Tgfb1i1 +/+ mouse retinas ( Figure 5B , larger Pax6 bands), despite the increase of Pax6-positive cells in Tgfb1i1 À/À mouse retina ( Figure 4C,D) . We did, instead, observe a specific increase in the level of Pax6DPD isoform, which is an alternative transcript produced at downstream of the a-enhancer sequence (Lakowski et al., 2007; Plaza et al., 1995) , in the Tgfb1i1 À/À mouse retina ( Figure 5B , smaller Pax6 bands). This Pax6DPD isoform is selectively enriched in Pax6 a-GFP-positive cells purified from P7 P6a-CreiGFP retinas by fluorescence activated cell sorting (FACS) ( Figure 5C ). Our results, thus, suggest hyperactivation of the Pax6 a-enhancer in Tgfb1i1 À/À retinas triggers ectopic expression of Pax6DPD isoform, but not the canonical Pax6.
We, next, investigated the role of a-enhancer-driven Pax6DPD expression in retinal cell fate determination by overexpressing Pax6DPD, which is connected with EGFP by internal ribosome entry site (IRES), in post-natal mouse retina ( Pax6 induces all amacrine cell types in a similar ratio observed in the normal mouse retina (Voinescu et al., 2009) . Mouse retinas expressing ectopic Pax6DPD show almost no EGFP-positive cells co-expressing OFF bipolar cell markers including Vsx1, Recoverin, and Bhlhb5 ( Figure 5F [bottom row], G; Figure 5-figure supplement 2B,D) . On the contrary, significant numbers of EGFP-positive cells coexpressed ON bipolar cell marker G0a in pCAGIG-Pax6DPD-electroporated mouse retinas, and the numbers are not significantly different from those in pCAGIG-electroporated samples ( Figure 5-figure supplement 2B,D) . EGFP-positive cells in pCAGIG-Pax6-electroporated mouse retinas, however, are almost absent of both ON and OFF bipolar cell marker co-expression ( Figure 5-figure  supplement 2B,D) . The results therefore suggest that Pax6DPD inhibits only OFF bipolar cell fate, while full-length Pax6 suppress both ON and OFF bipolar cell fates.
Pax6-dependent Pax6 a-enhancer activation is important for GABAergic amacrine cell fate maintenance Next, to inactivate the a-enhancer, we generated Pax6 DPBS/DPBS mice by deleting the auto-stimulatory PBS in the a-enhancer using the CRISPR/Cas9 system ( Figure 6A ; see Materials and methods for details). Despite the Pax6 a-enhancer being active in the mouse retina from embryo to adult, the gross morphologies of Pax6 We, therefore, measured the light-evoked activity of individual retinal circuits by performing multi-electrode array (MEA) recordings of RGCs, which represent the final circuit component in the retina. We found an increase in the basal firing rate and mean spike number, but no change in maximum spike rate for the light-ON responses of P60 Tgfb1i1 À/À retinas when compared to WT littermate controls ( Figure 7B [top], C). Conversely, we observed a reduction in the basal firing rate, maximum spike rate, and mean spike number for the ON responses of P60 Pax6 DPBS/DPBS retinas ( Figure 7B [bottom], D). Interestingly, a significant number of RGCs in P60 Tgfb1i1 À/À retinas do not return to the resting state after a transient light response (Figure 7B, arrowhead) . Considering the GABAergic identity of P6a amacrine cells and the increase of the cells in the Tgfb1i1 À/À retinas (Figure 4C,D; Figure 4 -figure supplement 1), it suggests this specific amacrine cell subset might disinhibit ON response by acting to other inhibitory retinal neurons in light-ON pathway (Chávez et al., 2010; Demb and Singer, 2012; Eggers et al., 2013) .
The low visual acuity and sustained light response of Tgfb1i1 À/À mouse retinas suggest that the hypersensitivity of the mice to light interferes with their detection of dark objects on brighter backgrounds ( Figure 7A, predicted views) . To test this hypothesis, we presented the mice with two different types of visual stimuli. First, we trained dark-adapted mice to associate a water reward with a flashing light stimulus. Then, we counted correct water-licking events in response to various intensities of flash light (Figure 7-figure supplement 3A) . Tgfb1i1 À/À mice not only learn this task faster than WT mice (Figure 7-figure supplement 3B ), but they also show more sensitive detection of the light stimuli ( Figure 7E) . However, in a second visual task requiring mice to detect a drifting grate stimulus after a light stimulus, Tgfb1i1 À/À mice perform worse than WT mice ( Figure 7F ; Figure 7-figure supplement 3C,D) . This suggests Tgfb1i1 À/À retinas are more slowly re-sensitized after light exposure than WT retinas. Conversely, the re-sensitization of Pax6 DPBS/DPBS retinas is significantly faster than WT retinas, despite being less sensitive to light ( Collectively, the results suggest that P6a amacrine cells control the tone of light-ON retinal pathway. The overall tone of light-ON pathway was increased in Tgfb1i1 À/À mouse retinas, which have extra P6a amacrine cells, whereas it is decreased in Pax6 DPBS/DPBS mouse retinas having reduced P6a amacrine cell number. Consequently, the light-ON pathway is augmented in Tgfb1i1 À/À mouse retinas and attenuated in Pax6 DPBS/DPBS mouse retinas to make the retinas hypersensitive and hyposensitive to light stimulus, respectively ( Figure 7B-E) . On the other hand, the Tgfb1i1 À/À mouse retinas cannot be re-sensitized as fast as WT retinas, while the Pax6 DPBS/DPBS mouse retinas can be re-sensitized more quickly than WT retinas after a light stimulus. Given the GABAergic identity of the cells, the P6a amacrine cells may inhibit the activity of post-synaptic partners, which are not identified yet but can be predicted as an inhibitory neuron in light-ON pathway ( Figure 7F ). Therefore, the results indicate that the proper number of P6a amacrine cells should be present in the retina to respond to light efficiently and adequately.
Discussion
Transcription factors frequently act in combination, allowing relatively few to generate the tremendous cellular diversity of the nervous system (Jessell, 2000) . Especially, the 'LIM code' mixes and matches LIM domain-containing transcription factors to direct tissue-and cell-specific gene expression (Gill, 2003; Shirasaki and Pfaff, 2002) . Lhx3, for example, specifies motor neuron cell fate in the spinal cord by forming a hetero-hexameric complex with Isl1 and nuclear LIM interactor (NLI) for the binding to the promoter of the Mnx1/Hb9 gene, whereas it specifies V2 interneuron cell fate by forming a hetero-tetrameric complex with NLI at the promoter of the Vsx2/Chx10 gene (Thaler et al., 2002) . Given that the various LIM homeodomain transcription factors, including Lhx2, Lhx3, Lhx4, and Lhx9, share a consensus target sequence (Gehring et al., 1994) , we speculate Isl1 partners with different LIM homeodomain transcription factors in a cell-context-dependent manner. In contrast to its relationship with Lhx3, Isl1 cooperates with Lhx2 to activate the a-enhancer in cultured cell lines (data not shown). However, this is unlikely to occur in vivo, because Lhx2 and Isl1 are expressed mutually exclusively in RPCs (Lhx2) and post-mitotic RGCs (Isl1) of the embryonic mouse retina, in GABAergic (Lhx2) and cholinergic amacrine cells (Isl1) in the mature retina, as well as in Mü ller glia (Lhx2) and ON bipolar cells (Isl1) (Balasubramanian et al., 2014; Elshatory et al., 2007; Gordon et al., 2013; Pan et al., 2008) . Moreover, Lhx2 flox/flox ;P6a-Cre retinas, which lack Lhx2 expression in the Cre-active lineages (Gordon et al., 2013) , show no change in the number of Pax6 a-enhancer-active cells (data not shown). This suggests Lhx2 may be dispensable for the activation of the Pax6 a-enhancer in the mouse retina. We propose that a Tgfb1i1 dimer links Isl1 and Lhx3 to form a hetero-tetrameric complex that represses the Pax6 a-enhancer (Figures 2 and 3) . The effects of Tgfb1i1 on the a-enhancer could be achieved by blocking Pax6's access the PBS sequence ( Figure 3G,H) . Alternatively, Tgfb1i1 may also recruit transcriptional co-repressors, such as NCoR (nuclear receptor co-repressor) (Heitzer and DeFranco, 2006) , to the Pax6 a-enhancer. These negative effects of Tgfb1i1 on the Pax6 aenhancer can be antagonized by Lmo4, which is persistently co-expressed with Pax6 in the retina and interferes with the interactions between Tgfb1i1 and Lhx3 and/or Isl1 (Duquette et al., 2010) ( Figures 2D and 3D) . Retinas lacking Lmo4 have fewer GABAergic amacrine cells than controls (Duquette et al., 2010) , which suggests Lmo4 may positively affect Pax6 a-enhancer-dependent GABAergic amacrine cell fate determination by inhibiting the formation of the LIM complex. However, the antagonistic regulation of the LIM complex by Tgfb1i1 and Lmo4 could not be applied to OFF bipolar cell fate determination, since OFF bipolar cell numbers are decreased commonly in Tgfb1i1 À/À and Lmo4-cko mouse retinas. Our results suggest that Tgfb1i1 and Lmo4 might involve in the development of different OFF bipolar cell subsets. The numbers of Bhlhb5-positive OFF bipolar cell subsets were not altered significantly in Tgfb1i1 À/À mouse retinas ( Figure 4E,F) , in contrast to a significant decrease in Lmo4-cko mouse retinas.
In addition to its canonical form, two alternative forms of Pax6, Pax6(5a) and Pax6DPD, are produced by alternative splicing and internal transcription initiation, respectively (Epstein et al., 1994; Mishra et al., 2002) . Pax6DPD does not affect Pax6 target gene expression via the conserved PBS (data not shown). Instead, as previously reported (Mikkola et al., 2001) , Pax6DPD may potentiate the expression of Pax6 target genes by interacting with full-length Pax6. This facilitation of Pax6-induced gene transcription by Pax6DPD may also occur with the Pax6 a-enhancer, resulting in a feed-forward activation of the a-enhancer. Alternatively, it may bind another promoter element containing the Pax6 homeodomain target DNA sequence (TAATT(/C)NA(/C)ATTA). Therefore, future studies will be needed to identify the targets of Pax6DPD in RPCs and post-mitotic retinal neurons. This will provide a full understanding of the distinctive roles Pax6 and Pax6DPD play in the retina.
Although the mechanisms of light adaptation and re-sensitization in the photoreceptors are fairly well-understood, how the inner retina contributes to these mechanisms is less clear. Acting downstream of rod bipolar cells that deliver visual signals from rod photoreceptors, A17 GABAergic amacrine cells provide a direct feedback inhibition to the rod bipolar cells (Chávez et al., 2010) . In parallel, an unidentified subset of GABAergic amacrine cells is also proposed to inhibit rod bipolar cells at the downstream of ON-cone bipolar cells, which can be activated by AII amacrine cells in the rod pathway as well as by daylight (Demb and Singer, 2012; Eggers et al., 2013) . GABAergic inhibition to the rod bipolar cells could be reduced in Tgfb1i1 À/À mouse retinas, leading to sustained ON responses ( Figure 7A) . Conversely, the ON pathway in Pax6 DPBS/DPBS mouse retinas is activated more transiently and is also more readily re-activated by subsequent visual stimuli ( Figure 7D) . Therefore, the P6a amacrine cells might attenuate those GABAergic inhibitions to rod bipolar cells and prevent premature inactivation of rod pathway. However, future studies should identify molecular and electrophysiological identities of the P6a amacrine cells and their pre-and post-synaptic partners to fully understand this visual adaptive circuits in the inner retina.
Materials and methods

DNA constructs and mouse lines
cDNA clones were generous gifts from Dr. Motoko Shibanuma (Hic-5/Tgfb1i1) and Dr. Seth Blackshaw (Lhx2 and Lhx9). The full-length and fragment DNAs used in this study were isolated by PCR amplification from these cDNAs. Tgfb1i1 À/À mice were generated as previously described (KimKaneyama et al., 2011) . Pax6 DPBS/DPBS mice were generated in this study using the CRISPR/Cas9 system (Cong et al., 2013) . To prepare sgRNA constructs, the pX330 vector was obtained from Addgene and digested with BbsI for insertion of a pair of phosphorylated dsDNA oligos (5'-CACC-GAAGTCGCTCCGGATCATGCA-3', 5-AAACTGCATGATCCGGAGCGACTTC-3') that target the PBS in the Pax6 a-enhancer. A T7 promoter was added to the 5' end of the sgRNA sequence in the pX330-sgRNA construct. This construct was then used as a template for in vitro transcription using the MEGAshortscript T7 kit (Life Technologies, CA). The in vitro transcribed sgRNAs (50 ng/ml) were injected into C57BL6/J mouse embryos (2 cell-stage) together with Cas9 mRNA (100 ng/ml; purchased from Toolgen Inc., South Korea). Then, these embryos were injected into the inner cell mass of ICR embryos. Four resulting F1 chimeric male mice were crossed to C57BL6/J female mice to obtain an F2 generation with the potential to carry deletions in the PBS. Then, tail DNA from each F2 mouse (n = 51) was prepared and used as a template for the PCR-amplification of the Pax6 aenhancer sequence. Each resulting PCR product was cloned into the pGEM-T vector for sequencing. Four F2 mice carry different heterozygous deletions in the PBS sequence were obtained. Before breeding with littermate Pax6 +/DPBS female mice, Pax6 +/DPBS male mice were crossed with C57BL6/J females for more than six generations to dilute any potentially OFF target mutations. All experiments using mice were performed according to the regulations of the KAIST-IACUC (KA2012-38).
Cell culture and luciferase assay HEK293T (RRID: CVCL_0063) and R28 retinal progenitor cells (RRID: CVCL_5I35) were obtained from ATCC and a gift from Dr. Gail Seigel (University of Rochester School of Medicine and Dentistry), respectively. These cell-lines are not in the list of commonly misidentified cell lines (by the International Cell Line Authentication Committee). These cells were regularly checked for mycoplasma contamination. The cells were maintained in DMEM supplemented with 10% fetal bovine serum (GIBCO, MA). Cells were combinatorially transfected with DNA constructs via the PEI (polyethylenimine) method (Polyscience, PA). The PCR-amplified mouse Pax6 a-enhancer sequence was fused to the pGL3-luciferase vector (Promega, WI) and co-transfected with DNA constructs of interest and pSV-b-gal plasmids. Transfected cells were harvested at 24 hr after transfection, and cell extracts were assessed for luciferase activity followed by normalization using b-galactosidase activity.
DNA affinity-capture assay
The (CA) 5 or (TG) 5 ssDNA oligonucleotides were coupled to CNBr-preactivated Sepharose 4B (GE Healthcare, IL) according to the manufacturer's protocol. R28 cells (~10 8 ) were incubated in a low salt buffer (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, and 0.5 mM PMSF) on ice for 10 min to rupture the plasma membranes. Then, the nuclei were collected by centrifugation. After treating the isolated nuclei with 10% (final v/v) NP-40 for 20 min, a solution containing 20 mM HEPES, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, and 1 mM PMSF was added to extract nuclear protein complexes. These nuclear extracts were then pre-cleared with a 5% (final v/v) slurry of protein A agarose beads (Invitrogen, CA) in a binding buffer (10 mM Tris-Cl pH 7.5, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, and 5% glycerol) at 4˚C for 30 min. The DF4 dsDNA oligonucleotides with 5'-(GT) 5 single-strand overhangs were synthesized with a 5' terminal amine modification and incubated with the R28 nuclear extracts overnight at 4˚C with agitation. The protein-DF4 dsDNA complexes were then incubated with the ssDNA-coupled Sepharose 4B for 6 hr at 4˚C, centrifuged, washed twice in binding buffer, washed twice in wash buffer (10 mM Tris-Cl pH 7.5, 1.2 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% Nonidet P-40), and washed twice in PBS. Protein-DF4 complexes bound to the column were then eluted in SDS sample buffer for SDS-PAGE and subsequent silver staining. The silver-stained protein bands, which were enriched in the (CA) 5 -coupled Sepharose 4B relative to the (TG) 5 -coupled Sepharose 4B, were isolated for trypsin digestion before being subjected to MALDI-TOF MS/MS analysis at the Korean Basic Science Institute (KBSI) proteomics core facility.
Electrophoretic mobility shift assay (EMSA)
Biotin-labeled and unlabeled dsDNA probes in binding buffer (75 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 mM Tris-HCl (pH 7.5), 6% glycerol, 2 mg BSA, and 500 ng poly (dI-dC)) were incubated on ice for 30 min with LIM proteins produced using the TNT Quick Coupled Transcription/Translation kit (Promega, WI). The EMSA was carried out on a 6% polyacrylamide gel in 0.5X TBE buffer. The DNA-protein complexes were then transferred to a nylon membrane (GE Healthcare, IL), and the biotin-labeled probes were detected using the Phototop-Star Detection Kit (New England BioLabs, MA) according to the manufacturer's recommendations.
Co-immunoprecipitation
P7 mouse retinas and transfected HEK293T cells were lysed in a buffer consisting of 10 mM Tris-HCl (pH 7.4), 200 mM NaCl, 1% Triton X-100, 1% NP-40, and a protease inhibitor cocktail (Invitrogen, CA). Cell lysates were centrifuged at 12,000 g for 10 min at 4˚C. The resulting supernatants were incubated with appropriate antibodies at 4˚C for 16 hr, and then pre-washed protein A/ G-sepharose (GE Healthcare, IL) was added to the samples. The protein A/G-sepharose immune complexes were washed five times with cell lysis buffer and subjected to SDS-PAGE and Western blotting (WB) for detection of co-immunoprecipitated proteins.
Chromatin immunoprecipitation (ChIP)
P7 mouse retinas were isolated, chopped, and cross-linked with 1% formaldehyde in PBS for 10 min at room temperature. After a 5 min incubation in 125 mM glycine, the tissues were homogenized and the nuclei were isolated. These nuclei were then subjected to sonication to break their chromatin into~600 bp fragments in a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1% Triton X-100, and a protease inhibitor cocktail (Invitrogen, CA). After preclearing with protein A agarose beads for 1 hr, the nuclear extracts were incubated for 16 hr with 1 mg of the appropriate antibody followed by incubation with protein A beads for 45 min at room temperature. The immune complexes were then washed three times with lysis buffer and then three more times with the same wash buffer containing 500 mM LiCl. After adding a Chelex 100 slurry to the washed beads, the DNA fragments were eluted for use as templates for qPCR. We used specific primers to amplify sequences in the ectoderm enhancer (fp1, 5'-CTAAAGTAGACACAGCCTT; rp1, 5'-GGAGACATTAGCTGAATTC) and the a-enhancer (fp2, 5'-GTGACAAGGCTGCCACAAGCGCC, rp2, 5'-CCGTGTCTAGACAGAAGCCCTCTC) of the mouse Pax6 gene. qPCR was performed using the iTaq fast SYBR Green Master Mix (BioRad, CA) with these same primers and analyzed using the CFX-Manager software (Bio-Rad, CA). Gene expression was normalized to that of a sample containing only protein A beads.
Immunohistochemistry
Frozen sections (12 mm) of embryonic heads and post-natal mouse eyes were incubated for 1 hr in a blocking solution containing 5% normal donkey serum and 5% normal goat serum in PBS containing 0.2% Triton X-100. The sections were incubated with the antibodies listed in Table 1 for 16 hr at 4˚C. Fluorescent images were obtained with a confocal microscope (Olympus FV100 and Zeiss LSM710) after staining with Cy3, Alexa 647, and Alexa 488-conjugated secondary antibodies at room temperature for 1 hr.
Fluorescence-activated cell sorting (FACS)
P6a-CreiGFP adult mouse eyes were dissected and placed in Hank's Balanced Salt Solution (HBSS; Life technologies) to remove the lens. Retinas were peeled from the eyes and placed in 1 ml HBSS containing activated 10 mg/ml papain (Sigma-Aldrich) for 5 min at 37˚C. Retinal cells were resuspended in HBSS with 2% FCS followed by centrifugation at 1600 rpm for 2 min. Cell pellets were then gently triturated in HBSS with 2% FCS, filtered through a 70 mm Filcons membrane prior to FACS analysis. GFP-positive retinal cells were then sorted in an Aria Fusion Cell Sorter (Becton Dickinson) at 495 nm excitation and 519 nm emission. Following FACS analysis, cells were collected by centrifugation at 1600 rpm for 5 min and the cells were lysed in a buffer containing 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1% Triton X-100, 0.1% SDS, and 150 mM NaCl.
Subretinal DNA electroporation
Electroporation experiments were performed as previously described (Matsuda and Cepko, 2004) . Approximately 0.5 ml (total; 5 mg/ml) DNA solution mixed with fast green dye was injected into the subretinal space of P0 mouse retinas, and square electric pulses were applied (100 V; five 50 ms pulses at 950 ms intervals). For CRISPR/Cas9-mediated deletion of Lhx3 gene, dsDNA oligos (sgRNA-Lhx3-1, 5'-(P)-CACCGGACCCGTCCCGGGAATCCGC-3' and 5'-AAACGCGGA TTCCCGGGACGGGTCC-3'; sgRNA-Lhx3-2, 5'-CACCGTGCTGGCGTTGTTGGCGCGA-3' and 5'-AAACTCGCGCCAACAACGCCAGCAC-3') were cloned into the pX330 vector before co-electroporation with the pCAGIG vector (molar ratio of pX330 constructs to pCAGIG is 1:0.5).
Multielectrode array (MEA) recordings
Mouse retinas were cut into 3 mm x 3 mm patches in artificial cerebrospinal fluid (ACSF) solution (124 mM NaCl, 10 mM glucose, 1.15 mM KH 2 PO 4 , 25 mM NaHCO 3 , 1.15 mM MgSO 4 , 2.5 mM CaCl 2 , and 5 mM KCl) bubbled with 95% O 2 + 5% CO 2 at pH 7.3-7.4˚C and 32˚C. Retinal patches were then mounted, ganglion cell layer down, on a planar 8 Â 8 MEA, and the light-evoked RGC spikes were recorded using the MEA60 system (Multi Channel Systems GmbH, Germany). White light stimuli were applied with a DLP projector (Hewlett Packard, ep-7122) focused onto the photoreceptor layer of the retina through four convex lenses. Light intensity was 170-200 mW/cm 2 (116-136 lux) in 8-10 mW/cm 2 (5.5-6.8 lux) background illumination. Light stimuli were given in 1 s pulses with 6 s inter-pulse intervals to a total of 40 pulses per retina. All experiments were performed after sufficient dark adaptation (>1 hr).
Visual acuity test
Mouse visual acuity was measured with the OptoMotry system (Cerebral Mechanics Inc.) as previously described (Prusky et al., 2004) . Mice, of which genotypes are not determined before the measurement, were adapted to ambient light for 30 min and then placed on the stimulus platform, which is surrounded by four computer monitors displaying grating patterns randomly presented by the OptoMotry software. Mice that stopped moving and began tracking the gratings with reflexive head movements in concert with their rotation were counted as successful visual detection events. The detection thresholds were then obtained from the OptoMotry software.
Visual performance test A.surgery Adult mice (postnatal days 35-40) were anesthetized with isoflurane (1.5% induction and 1.0% maintenance) and fixed to a stereotaxic frame. Body temperature was maintained at 37˚C. Customdesigned head plates were attached to the skull with small screws (Small Parts) and dental cement (Lang Dental).
B.behavior test Visual detection task
In this task, head plate-implanted mice (P45-P80) were trained to lick a water nozzle when they detected a visual stimulus (114 Lux). All mice used for this task were water-deprived for 1 day before beginning the training protocol. For the visual stimulus, we presented a full-field flashing light five times (10 Hz for 500 ms) through a gamma-corrected LCD monitor placed 10 cm from the left eye. Each stimulus trial began with a visual stimulus (500 ms in duration) and ended with a 2 s inter-trial period. Non-stimulus trials were randomly interleaved with stimulus trials using custom code (Presentation). We detected each lick through a custom-made lickport (4.0 mm ID) using a transistor-based lickometer system. Licks detected during the final 2 s of stimulus trials (i.e., in the response window) were rewarded with 4 ml of water (on). We delivered water rewards by gravity into the lickport under the control of a solenoid valve. Licks detected during the response window of non-stimulus trials were punished with a mild air puff (300 ms) and a longer inter-trial interval (8 s, timeout) (off). We delivered compressed air puff punishments (10 psi) through a plastic tip (1.0 mm ID) located 2 cm from the face and controlled by a solenoid valve. Mice whose spontaneous lick rate during non-stimulus trials fell below 0.4 were advanced to the next phase. In the next phase, we measured lick rates in response to nine different intensities of visual stimuli presented randomly with equal probability.
Visual adaptation task
We trained mice to discriminate a continuous light from a drifting grate stimulus presented after continuous light under a simple go/no-go protocol. Training proceeded in two steps: conditioning and discrimination. For conditioning (2-8 days), we trained each mouse to lick in response to continuous light. Each trial began with a continuous light (go stimulus, 2 s duration) and ended with an inter-trial period of 2 s. Licks detected in the final 2 s of the trial (i.e., in the response window) were rewarded with 10 ml of water for 2 s. During the conditioning phase, water rewards were still given after continuous light even if the animal failed to lick during the response window. Mice exceeding 300 licks within 1 hr were advanced to the discrimination phase. For discrimination (15 days), we trained mice to lick only when continuous light (2 s) was presented (go trial) and not to lick when a drifting horizontal grate stimulus (1 s) was presented after a continuous light stimulus (1 s) (no-go trial). All visual stimuli used for training were fixed at 57 Lux. We never presented the same type of stimulus more than three consecutive times. Licks within the response window of go trials were rewarded with water (4 ml) for 2 s, and licks within the response window of no-go trials were punished with mild air puffs (300 ms) and a longer inter-trial interval (8 s, timeout). Mice were neither rewarded nor punished for misses (i.e., no lick in a go trial) or correct rejections (i.e., no lick in a nogo trial). Training ended when the mouse stopped licking for 10 consecutive go trials.
Mice that reached threshold performance (lick rates in no-go trials < 0.4) were advanced to the next phase. In the next phase, we presented five different intensities of a continuous light higher or equal to 57 lux before a drifting grate stimulus fixed at 57 lux. We presented all stimuli randomly with equal probability.
